Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
Document Details
Form
Filing Date
Feb 13, 2023
Document Date
Feb 13, 2023
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
Other
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/